Integrated Treatment to Achieve Functional Recovery for First-Episode Psychosis

Abstract EN

This study describes an integrated treatment approach that was implemented to enhance functional recovery in first-episode psychotic patients.

Patients were randomized to two treatment conditions: either to an integrated treatment approach: pharmacotherapy, psychosocial treatment, and psychoeducation (experimental group: N=39) or to medication alone (control group: N=34).

Patients were evaluated at baseline and after one year of treatment.

Functional recovery was assessed according to symptomatic and functional remission.

At the end of treatment, experimental patients showed a 94.9% of symptomatic remission compared to 58.8% of the control group.

Functional remission was 56.4% for the experimental group and 3.6% for the control group, while 56.4% of the experimental group met both symptomatic and functional remission criteria and were considered recovered compared to 2.9% of the control group.